BackAntares Pharma Overview

Antares Pharma Inventory

Track Antares Pharma's inventory ($12M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Inventory
$11.59M
↓ 40.90% YoYΔ $-8.02M vs prior year quarter

Peer average

Loading

Antares Pharma Inventory History

Loading

Antares Pharma vs. peers: Inventory Comparison

Loading

Antares Pharma Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Antares Pharma (ATRS) FAQ

Antares Pharma (ATRS) currently reports a inventory of $12M as of March 2022. That compares with $20M in the prior-year period — down 40.9% year over year. Use the charts on this page to explore Antares Pharma's inventory history and peer comparisons.

Antares Pharma's inventory decreased from $20M to $12M — a 40.9% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Antares Pharma reported $12M in inventory as of March 2022. That compares with $20M in the prior-year period — down 40.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Antares Pharma, and consider following ATRS for alerts when major investors trade the stock.

Antares Pharma is classified in the Healthcare sector. On inventory, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATRS with unrelated industries.